Glopisine (Finasteride)

Glopisine is indicated for two primary therapeutic areas that involve androgen‑dependent processes.

• Treatment of benign prostatic hyperplasia (BPH) in adult men to improve urinary flow and reduce prostate size.
• Management of male pattern hair loss (androgenetic alopecia) to promote hair regrowth and slow further loss.
• May be prescribed as part of a comprehensive BPH management plan that includes lifestyle and other pharmacologic measures.
• Used under medical supervision for patients who meet specific diagnostic criteria for the above conditions.

Finasteride can cause a range of side effects, most of which are mild and reversible. Serious adverse events are less common but require medical attention.

Common

• Decreased libido or sexual desire.
• Erectile dysfunction.
• Reduced ejaculate volume.
• Breast tenderness or enlargement.
• Rash or mild skin irritation.
• Dizziness or headache.

Serious

• Allergic reactions such as swelling of the face, lips, or throat.
• Persistent breast pain or lumps.
• Signs of depression or mood changes.
• Testicular pain.
• Severe liver enzyme abnormalities (rare).

Before starting Glopisine, certain health considerations should be reviewed with a healthcare professional.

• Not recommended for use in women or children; pregnancy category X due to risk of fetal abnormalities.
• Men with a history of prostate cancer should discuss potential risks and benefits.
• Patients with liver impairment may require monitoring of liver function tests.
• Caution is advised in individuals with a history of depression or low mood.
• Regular follow‑up is recommended to assess treatment response and any emerging side effects.
• Inform the prescriber of any concurrent use of hormonal therapies or supplements.

Finasteride may interact with other medications, altering its effectiveness or increasing the risk of adverse effects.

Avoid

• Concomitant use of strong CYP3A4 inhibitors (e.g., ketoconazole) that could increase finasteride plasma levels.
• Hormonal agents such as testosterone replacement therapy that may counteract the drug’s mechanism.

Use with caution

• Anticoagulants or antiplatelet drugs, as rare bleeding disorders have been reported.
• Other 5‑alpha‑reductase inhibitors (e.g., dutasteride) due to additive hormonal effects.
• Medications that affect liver metabolism, requiring periodic liver function monitoring.
• Herbal supplements like saw palmetto, which also influence DHT pathways.